EMA publishes agenda for 17-20 July CHMP meeting

EMA

17 July 2023 - The EMA has published a draft agenda for this week's CHMP meeting.

The CHMP is due to issue opinions for the following technologies:

  • Respiratory syncytial virus vaccine
  • Cabotegravir
  • Degarelix acetate
  • Crisantaspase
  • Cedazuridine with decitabine
  • Adagrasib
  • Ritlecitinib tosylate
  • Gefapixant
  • Elacestrant dihydrochloride
  • Talquetamab
  • Epcoritamab
  • Tislelizumab
  • Tocilizumab
  • Natalizumab
  • Aflibercept

Read CHMP agenda 

Michael Wonder

Posted by:

Michael Wonder